Microfluidic Reactor Geometries for Radiolysis Reduction in Radiopharmaceuticals
Overview
Nuclear Medicine
Authors
Affiliations
Autoradiolysis describes the degradation of radioactively labeled compounds due to the activity of the labeled compounds themselves. It scales with activity concentration and is of importance for high activity and microfluidic PET tracer synthesis. This study shows that microfluidic devices can be shaped to reduce autoradiolysis by geometric exclusion of positron interaction. A model is developed and confirmed by demonstrating in-capillary storage of non-stabilized [(18)F]FDG (2-[(18)F]Fluoro-2-deoxy-d-glucose) at max. 23 GBq/ml while maintaining >90% radiochemical purity over 14 h.
Multi-GBq production of the radiotracer [F]fallypride in a droplet microreactor.
Wang J, Chao P, Slavik R, van Dam R RSC Adv. 2022; 10(13):7828-7838.
PMID: 35492189 PMC: 9049805. DOI: 10.1039/d0ra01212b.
Holler J, Renmaelmo B, Fjellaksel R EJNMMI Radiopharm Chem. 2022; 7(1):2.
PMID: 35201511 PMC: 8873310. DOI: 10.1186/s41181-022-00154-3.
Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical production.
Frank C, Winter G, Rensei F, Samper V, Brooks A, Hockley B EJNMMI Radiopharm Chem. 2019; 4(1):24.
PMID: 31659546 PMC: 6751239. DOI: 10.1186/s41181-019-0077-0.
Digital Microfluidics: A New Paradigm for Radiochemistry.
Keng P, van Dam R Mol Imaging. 2015; 14(12):13-14.
PMID: 26650206 PMC: 4734895. DOI: 10.2310/7290.2015.00030.
Javed M, Chen S, Kim H, Wei L, Czernin J, Kim C J Nucl Med. 2013; 55(2):321-8.
PMID: 24365651 PMC: 4494735. DOI: 10.2967/jnumed.113.121053.